← GLP-1
Episodes featuring GLP-1
115 episodes, newest first.
- Sep 1, 2026
Testosterone enters the menopause conversationunPAUSED with Dr. Mary Claire HaverSep 1, 2026 - Aug 26, 2026
Zapier’s CEO turns AI into an executive operating systemMy First MillionAug 26, 2026 - Aug 25, 2026
Brain health starts decades before symptoms appearHabits and HustleAug 25, 2026 - Aug 25, 2026
Newton sees volatility before a potential year-end market surgeThoughtful Money with Adam TaggartAug 25, 2026 - Aug 24, 2026
Harvard geneticist David Sinclair projects human trials for cellular age reversalModern WisdomAug 24, 2026 - Aug 20, 2026
Brain inflammation may be a metabolic problem in disguiseExtend Podcast with Darshan Shah, MDAug 20, 2026 - Aug 18, 2026
Trump claims credit as prescription prices fallLetters from an American Aug 18, 2026 - Aug 16, 2026
GLP-1 drugs reshape appetite science and metabolic medicineThe Rest Is ScienceAug 16, 2026 - Aug 14, 2026
Room assignments turn a Vegas getaway into a friendship trialWatch What CrappensAug 14, 2026 - Aug 13, 2026
Koniver challenges medicine’s shortcuts with personalized longevity careThe Shawn Ryan ShowAug 13, 2026 - Aug 12, 2026
GLP-1 treatment works best beyond the scaleThe Dr. Hyman ShowAug 12, 2026 - Aug 12, 2026
Strong earnings meet stubborn valuation fearsEquity Mates Investing PodcastAug 12, 2026 - Aug 6, 2026
Brittany’s breakup keeps The Valley reunion stuck on JaxWatch What CrappensAug 6, 2026 - Jul 22, 2026
Longevity startup bypasses Silicon Valley to build in JapanThis Week in StartupsJul 22, 2026 - Jul 20, 2026
Dr. Tommy Wood outlines how physical and mental friction rewires the brainHuberman LabJul 20, 2026 - Jul 2, 2026
Mitochondria expert explains how cellular energy reverses gray hair and agingThe Diary Of A CEO with Steven BartlettJul 2, 2026 - Jan 21, 2026
Greenland tariff fears expose market froth and crowded tradesMad Money w/ Jim CramerJan 21, 2026 - Jan 9, 2026
Cramer urges caution as speculation collides with market momentumMad Money w/ Jim CramerJan 9, 2026 - Dec 18, 2025
Cramer weighs buybacks, AI rivalry and tariff risksMad Money w/ Jim CramerDec 18, 2025